Blue Edge Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-12,753
Closed -$1.14M 92
2018
Q1
$1.14M Sell
12,753
-709
-5% -$68.1K 0.46% 54
2017
Q4
$1.4M Buy
13,462
+120
+0.9% +$13.5K 0.56% 50
2017
Q3
$1.95M Sell
13,342
-466
-3% -$63.5K 0.89% 31
2017
Q2
$1.79M Sell
13,808
-52
-0.4% -$6.37K 0.85% 34
2017
Q1
$1.72M Hold
13,860
0.86% 35
2016
Q4
$1.6M Sell
13,860
-280
-2% -$31.2K 0.9% 38
2016
Q3
$1.48M Hold
14,140
0.81% 38
2016
Q2
$1.39M Sell
14,140
-239
-2% -$24.7K 0.77% 38
2016
Q1
$1.44M Buy
14,379
+43
+0.3% +$4.43K 0.85% 38
2015
Q4
$1.72M Sell
14,336
-26
-0.2% -$3.01K 1.12% 27
2015
Q3
$1.55M Sell
14,362
-3
-0% -$372 1.11% 28
2015
Q2
$1.66M Sell
14,365
-152
-1% -$17.4K 1.08% 24
2015
Q1
$1.67M Buy
14,517
+600
+4% +$71.7K 1.12% 23
2014
Q4
$1.56M Sell
13,917
-34
-0.2% -$3.59K 1.07% 26
2014
Q3
$1.32M Sell
13,951
-621
-4% -$56K 0.93% 31
2014
Q2
$1.25M Hold
14,572
0.85% 34
2014
Q1
$1.02M Hold
14,572
0.71% 42
2013
Q4
$1.23M Buy
+14,572
New +$1.15M 0.9% 31

Other funds holding CELG

Blue Edge Capital's CELG Position: Q2 2018 in Review

Blue Edge Capital sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 12,753 shares — an estimated $1.14M sold.

Blue Edge Capital first reported a position in CELG in Q4 2013 and held it in 18 quarters. The position peaked at $1.95M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Blue Edge Capital reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Blue Edge Capital sold 12,753 Celgene Corp shares in Q2 2018, an estimated $1.14M.
  • Blue Edge Capital first reported a position in Celgene Corp in Q4 2013 and held it in 18 quarters.
  • Blue Edge Capital's Celgene Corp position peaked at $1.95M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Blue Edge Capital's 13F filing for Q2 2018, filed 14 Aug 2018.